Although no individual immuno-histochemical markers can clearly distinguish between HB and HCC, ABC-MYC tumors showed combined staining profiles that were more consistent with HB, i.e., AFP+, glypican-3+, glutamine synthetase+, Sal4+, and arginase-1+. The gene discussed is AFP; the disease is hemoglobin measurement.